Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CONMED (CNMD)

CONMED names Andrew Moller interim principal financial officer effective March 15, 2026

Neutral Impact 3 of 5 leadership Written later

CONMED Corporation said Andrew Moller, currently Principal Accounting Officer and Vice President, Corporate Controller, will serve as Interim Principal Financial Officer starting March 15, 2026. The filing reports no change to his compensation for the interim role, so the change is administrative in nature and reflects a finance leadership appointment rather than a financial result.

Key points

  • Andrew Moller, age 51, to become Interim Principal Financial Officer effective March 15, 2026
  • Moller joined CONMED in January 2025 as Vice President, Corporate Controller and became Principal Accounting Officer in April 2025
  • Previously served at Smith & Nephew from May 2019 to December 2024, most recently as Global Controller and CFO Asia-Pacific
  • No change to his compensation arrangements in connection with the interim appointment

The filing

CompanyCONMED (CNMD)
Form8-K, current report
Filed with the SECMar 13, 2026, 4:01 PM ET
Accession number0001213900-26-027658

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.